ArticleScience and engineering ethics2025
Enhancing Soldiers for Future Warfare: Good Science; Bad Ethics?
Article in Science and engineering ethics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Ethical concerns dog emerging technologies designed to enhance warfighter performance. Brain-computer interfaces, exoskeletons, and mind- or body-altering drugs raise fears about risky, invasive, and experimental medical procedures that offer armies physically and cognitively superior soldiers that will dictate and disrupt the course of future war. What counts as enhancement, however, has been subject to longstanding and passionate debate. This study aims to put an end to this dispute by employing a conjoint experimental design to survey a group of military and professional experts from across the world to explore how definitional perceptions of enhancement influence ethical acceptability. Two main findings emerge. First, we find that there already exists a broad agreement about what constitutes enhancement, and this consensus spans countries, discipline, political orientation, and age. Future policy may now be able to accommodate a definition of enhancement that is widely shared among members of the international community. Second, across the board, ethical acceptability diminishes as medical technologies aim for transhuman warfighting capabilities. Enhancement research and development for military purposes must navigate the conflicting ethical demands of medical experimentation and lawful war. Human enhancement is not morally unacceptable but ethically precarious, requiring regulation, oversight, and transparency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.